Katleen Verleysen

Chief Executive Officer

Katleen Verleysen, PhD, is Chief Executive Officer of miDiagnostics, a role she has held since 2021, focused on building the operational and commercial infrastructure needed to support the company's global growth while strengthening partnerships across the pharmaceutical and healthcare industries. She has received multiple international recognitions, including European CEO of the Year in 2024 and 2025, Top Innovative Chief Executive Officer in Life Sciences at BIO-Europe 2025, the Burj CEO award for Exemplary Woman of Achievement in 2025, and recognition for Outstanding Leadership in Clinical Molecular Diagnostics for Europe in Business Worldwide Magazine's 2026 Global Corporate Excellence Awards. She brings experience from earlier roles at 4Tissue, FlexCap Consulting and ImmuneXpress Inc.